275 related articles for article (PubMed ID: 20833272)
1. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.
Hernández-Molina G; Leal-Alegre G; Michel-Peregrina M
Autoimmun Rev; 2011 Jan; 10(3):123-5. PubMed ID: 20833272
[TBL] [Abstract][Full Text] [Related]
2. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS).
Rischmueller M; Lester S; Chen Z; Champion G; Van Den Berg R; Beer R; Coates T; McCluskey J; Gordon T
Clin Exp Immunol; 1998 Feb; 111(2):365-71. PubMed ID: 9486405
[TBL] [Abstract][Full Text] [Related]
3. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
4. Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome.
Maran R; Dueymes M; Pennec YL; Casburn-Budd R; Shoenfeld Y; Youinou P
J Autoimmun; 1993 Jun; 6(3):379-87. PubMed ID: 8397718
[TBL] [Abstract][Full Text] [Related]
5. [Immunogenetics of the Sjogren's syndrome in southern Spain].
García Portales R; Belmonte Lope MA; Camps García MT; Ocón Sánchez P; Alonso Ortiz A; Guil García M; de Ramón Garrido E
An Med Interna; 1994 Feb; 11(2):56-61. PubMed ID: 8193233
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
[TBL] [Abstract][Full Text] [Related]
7. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
Locht H; Pelck R; Manthorpe R
J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
[TBL] [Abstract][Full Text] [Related]
9. Serological profiles in subgroups of patients with Sjögren's syndrome.
Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
[TBL] [Abstract][Full Text] [Related]
10. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
[TBL] [Abstract][Full Text] [Related]
11. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
16. [The autoantibody profile in Sjögren's syndrome].
Manoussakis MN; Pange PJ; Moutsopulos HM
Ter Arkh; 1988; 60(4):17-20. PubMed ID: 3260689
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen-specific memory B cells in primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Bredholt G; Brun JG; Brokstad KA
Scand J Immunol; 2012 Jan; 75(1):61-8. PubMed ID: 21916919
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
19. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
20. [Detection of anti-Ro(SS-A) by using immunoimprint. Comparison with double diffusion in agar. Apropos of a series of 63 primary Gougerot-Sjögren syndromes].
Meyer O; Haim T; Bourgeois P; Palazzo E; Ribard P; Belmatoug N; Kahn MF
Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):149-55. PubMed ID: 1905419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
